Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

A jury unanimously found that Axonics did not infringe any of the three patents-in-suit brought against the company by Medtronic in a patent infringement lawsuit in the U.S. District Court for the ...

Specifically Medtronic redesigned ... The change of reed-switch to a Hall sensor. Furthermore, it has developed simple programming with clear steps to provide predictable pacemaker performance ...

One challenger to Medtronic is Insulet ... of the Omnipod using the algorithm with a Dexcom continuous glucose sensor. Overall, young users spent over 70% of daytime and 85% or greater of ...

Automated and sustainable distribution centre for adidas for Southern and Eastern Europe in Mantova, Northern Italy.

Alcatraz AI, a global provider of frictionless, AI-powered biometric access control solutions revolutionizing security through facial authentication, today announced the launch of their latest product ...

Continuous Glucose Monitoring (CGM) Systems Market The increasing incidence of diabetes and the detection of patient's blood glucose levels are raising the demand for continuous global monitoring ...